Oral Squamous Cell Carcinoma Survival Predictors for 510 Patients

A retrospective clinical study of 510 patients diagnosed with oral squamous cell carcinoma (OSCC) validated the prognostic value of tumor budding and tertiary lymphoid structures. The study established a TB/TLS index and developed a nomogram prediction model incorporating clinicopathological factors. The dataset was created by Zhuqin Xiang and last updated on June 3, 2026.

Use Cases

• Predicting patient survival based on integrated tumor budding and tertiary lymphoid structure analysis.
• Validating the TB/TLS index as a superior prognostic biomarker compared to single factors.
• Building and calibrating nomogram models for clinical outcome prediction.
• Analyzing the 'invasion-immune' status within the OSCC tumor microenvironment.

Strengths

• Includes data from 510 patients, providing a substantial cohort for analysis.
• Integrates two distinct biomarkers (tumor budding and tertiary lymphoid structures) into a single prognostic index.
• The prediction model was externally validated, demonstrating moderate performance despite cohort differences.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small (16.4 KB), indicating limited scope.

Provenance

Source

figshare

Collection Method

Retrospective study using hematoxylin and eosin staining assessments on patient samples.

Freshness

Last updated 2026-06-03 04:47:24; freshness should be verified.